Northwest & Ethical Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,187
| Closed | -$669K | – | 417 |
|
|
2022
Q1 | $669K | Sell |
1,187
-294
| -20% | -$166K | 0.02% | 334 |
|
|
2021
Q4 | $1.12M | Sell |
1,481
-2,741
| -65% | -$2.07M | 0.03% | 291 |
|
|
2021
Q3 | $3.15M | Sell |
4,222
-32
| -0.8% | -$23.9K | 0.1% | 203 |
|
|
2021
Q2 | $2.74M | Hold |
4,254
| – | – | 0.09% | 207 |
|
|
2021
Q1 | $2.43M | Buy |
+4,254
| New | +$2.43M | 0.09% | 244 |
|
|
2020
Q3 | – | Sell |
-2,434
| Closed | -$1.1M | – | 402 |
|
|
2020
Q2 | $1.1M | Buy |
+2,434
| New | +$1.1M | 0.05% | 296 |
|
|
2018
Q4 | – | Sell |
-200
| Closed | -$62.6K | – | 368 |
|
|
2018
Q3 | $62.6K | Sell |
200
-300
| -60% | -$93.9K | ﹤0.01% | 347 |
|
|
2018
Q2 | $144K | Sell |
500
-100
| -17% | -$28.9K | 0.01% | 337 |
|
|
2018
Q1 | $150K | Buy |
+600
| New | +$150K | 0.01% | 331 |
|